Phytochimie

Cathrin Brisken, MD, PhD, is Associate Professor of Life Sciences at the Swiss Federal Institute of Technology Lausanne (EPFL). Dr. Brisken is internationally recognized for her work on endocrine control of mammary gland development and breast carcinogenesis. Dr. Brisken received her MD and her PhD degree in Biophysics from the Georg August University of Göttingen, Germany. She completed her postdoctoral work in cancer biology with Dr. R.A. Weinberg at the Whitehead Institute of Biomedical Research in Cambridge, MA, USA. She previously held appointments at the Cancer Center of the Massachusetts General Hospital, Harvard Medical School, Boston and the Swiss Institute for Experimental Cancer Research (ISREC). Research in Dr. Brisken’s laboratory focuses on the cellular and molecular underpinnings of estrogen and progesterone receptor signaling in the breast and the respective roles of these hormones and hormonally active compounds in carcinogenesis. The aim is to understand how recurrent exposures to endogenous and exogenous hormones contribute to breast carcinogenesis in order to better prevent and treat the disease. The laboratory has pioneered in vivo approaches to genetically dissect the role of the reproductive hormones in driving mouse mammary gland development and shown how they control intercellular communication. Dr. Brisken’s group has developed ex vivo and humanized mouse models using patient samples to study hormone action in human tissues in normal settings and during disease progression. Dr. Brisken is member of the International Breast Cancer Study Group (IBCSG) Biological Protocol Working Group. She served as Dean of EPFL Doctoral School (more than 2000 PhD students in 18 PhD programs), as member of the Hinterzartener Kreis, the oncology think-tank associated with the German Science Foundation, and numerous Swiss, European, and AACR committees. She co-founded the International Cancer Prevention Institute.

Johan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways. Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards. Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.

Depuis 2007 Fondateur et directeur de l'EPFL ECAL Lab. Quelques projets marquants: Sunny Memorie avec l'ECAL, l'ENSCI-Les Ateliers (Paris), le Royal College of Arts (Londres), le California College of the Arts (San Francisco) Give Me More (Réalité Augmentée) Hidden Carbon (Matériaux composites, avec l'ECAL etl'ENSCI-Les Ateliers (Paris) Cours postgrade: certificate of Advanced Studies en Réalité Augmentée Depuis oct. 2000 Adjoint du Président de l'EPFL pour la communication 1998-2000 Présentateur et chef d'édition du Journal Télévisé /Télévision suisse romande 1994-2000 Journaliste-reporter, Télévision Suisse romande 1994-2000 Fondateur et directeur de ICAT (Institut pour la communication et l'analyse de Technologies ) 1991-2000 Journaliste scientifique au Journal de Genève (formation professionnelle RP) 1986-1991 Etudes et diplôme d'ingénieur en sciences des matériaux, EPFL. Prix Matériaux 91

I was born in Charleville-Mézières, France, on July 28, 1979. I graduated in electrical engineering from the University of Reims, France, in 2002. I received the M.S degree in image and signal processing from the University of Cergy-Pontoise, France, in 2003. From October 2003 to September 2007, I have been pursuing a Ph.D. degree at Grenoble National Polytechnical Institute (INPG), France. My supervisors were Pierre-Olivier Amblard and Steeve Zozor . I was teaching assistant from October 2006 to August 2007 at the Institute of Technology of Grenoble (IUT GEII2). Since November 2007, I have a post-doctoral position with the LTS1 Team, EPFL and MOTILIS MEDICA S.A. . My research interests are non linear and adaptive signal processing, fluctuations, biomedical signal processing. I am also an organizer of the Nonlinearity and noise meetings , a collaboration between several researchers working on the field of nonlinear signal processing.